The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. - Conley BA; Staudt L; Takebe N; Wheeler DA; Wang L; Cardenas MF; Korchina V; Zenklusen JC; McShane LM; Tricoli JV; Williams PM; Lubensky I; et al. (Journal of the National Cancer Institute, 2021)